Poly Medicure Ltd

BSE: POLYMED531768ISIN INE205C01021

Healthcare
Medical Equipment & Supplies
BSE 500

Share price

₹1,587.65+90.60 (+6.05%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹2,093.95
52W low: ₹1,184.00
Off 52W high: -24.18%
1M return: -1.84%
3M return: -6.97%
6M return: -4.14%
1Y return: -18.70%
20D avg volume: 6,994
50 DMA: ₹1,637.78
200 DMA: ₹1,546.41

Key ratios Consolidated

Market cap: ₹16,093 Cr
Current price: ₹1,587.65
52W high / low: ₹2,093.95 / ₹1,184.00
Face value: ₹5.00
P/E: 51.43
P/B: 5.18
EPS (TTM): ₹30.87
Book value / share: ₹306.45
ROE: —
ROCE: 13.20%
Operating margin: —
Net margin: —
Debt / equity: 0.11
Net debt: ₹290.39 Cr
Interest cover: 24.06
Dividend yield: 0.22%
Dividend / share (TTM): ₹3.50
Payout: 11.34%
Cash conversion cycle: 163.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	525.38	534.51	493.66	443.88	403.21	440.83	424.21	420.01	384.78	378.07	339.60	337.29
	33.41	17.76	26.26	33.94	41.69	24.31	21.80	26.10	16.92	14.97	16.57	14.09
	558.78	552.27	519.92	477.83	444.90	465.14	446.01	446.11	401.70	393.05	356.17	351.39
	443.03	468.75	417.19	357.10	323.28	344.56	334.51	328.88	303.67	300.82	269.06	271.27
	183.88	155.08	146.17	157.07	141.07	141.96	141.95	154.88	132.57	126.61	118.72	114.20
	2.67	1.38	1.58	1.23	0.86	2.51	3.32	1.21	0.89	1.35	1.05	2.85
	126.90	126.14	115.20	88.83	75.11	78.89	77.89	78.09	70.79	69.44	60.40	58.32
	6.50	6.41	5.96	2.97	2.95	2.17	3.33	3.34	3.16	3.12	3.47	2.22
	36.25	38.23	28.76	24.93	23.26	21.03	21.51	20.85	19.65	16.20	16.21	15.99
	133.63	119.81	111.51	104.71	94.73	95.08	81.27	88.91	77.69	75.94	66.22	68.48
	115.75	83.51	102.73	120.73	121.62	120.57	111.51	117.23	98.02	92.23	87.11	80.11
	0.00	0.00	-6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	115.75	83.51	95.93	120.73	121.62	120.57	111.51	117.23	98.02	92.23	87.11	80.11
	32.03	20.18	26.80	29.89	29.86	31.02	28.00	30.53	24.42	24.10	22.81	18.76
	85.27	65.04	70.81	91.80	93.08	91.83	85.23	87.45	74.04	68.36	65.02	62.19
	8.49	6.54	7.00	9.06	9.19	8.92	8.48	9.01	7.71	7.12	6.78	6.48
Key metrics
	158.50	128.15	130.65	148.63	147.83	143.77	136.35	141.42	120.83	111.55	106.79	98.32
	30.20%	24.00%	26.50%	33.50%	36.70%	32.60%	32.10%	33.70%	31.40%	29.50%	31.40%	29.10%
	16.20%	12.20%	14.30%	20.70%	23.10%	20.80%	20.10%	20.80%	19.20%	18.10%	19.10%	18.40%
	—	2.70%	—	4.00%	—	4.30%	—	—	—	—	—	—
	30.30%	21.30%	16.40%	5.70%	4.80%	16.60%	24.90%	24.50%	—	—	—	—
	-8.40%	-29.20%	-16.90%	5.00%	25.70%	34.30%	31.10%	40.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	1,997	1,875	1,670	1,376	1,115	923.06	786.47	687.24	610.83	521.68
	111.37	120.08	89.13	58.75	36.19	37.90	18.41	18.46	18.27	14.38
	2,109	1,995	1,759	1,435	1,151	960.97	804.88	705.70	629.09	536.05
	1,686	1,567	1,312	1,093	915.85	768.17	628.14	582.12	530.42	440.54
	642.20	599.39	571.36	464.79	424.31	352.37	266.58	225.22	194.92	171.12
	6.86	5.06	7.94	7.02	5.21	10.66	3.08	0.71	14.54	4.37
	457.07	402.26	301.53	245.91	202.75	163.62	141.76	138.76	116.61	99.13
	21.84	18.29	12.00	11.30	8.84	4.25	8.51	18.31	11.75	9.96
	128.17	115.52	82.64	63.93	57.17	53.95	47.52	40.53	37.29	—
	469.66	433.88	360.77	270.10	223.42	179.50	155.35	155.53	145.95	125.85
	422.72	428.59	447.33	341.74	235.56	192.80	176.74	123.58	98.68	95.51
	-6.80	-6.80	0.00	0.00	0.00	0.00	0.00	0.00	1.40	1.24
	415.92	421.79	447.33	341.74	235.56	192.80	176.74	123.58	100.08	96.75
	108.90	106.74	113.96	86.01	58.21	48.74	44.18	29.84	34.67	26.16
	312.92	320.73	338.56	258.26	179.28	146.51	135.87	95.88	65.40	70.59
	31.09	31.79	34.13	26.92	18.69	15.28	15.25	10.86	7.41	—
Key metrics
	565.93	555.60	541.97	416.97	301.57	251.00	232.77	182.42	149.12	106.71
	28.33%	29.60%	32.50%	30.30%	27.00%	27.20%	29.60%	26.50%	24.40%	20.50%
	15.67%	17.10%	20.30%	18.80%	16.10%	15.90%	17.30%	14.00%	10.70%	13.50%
	—	13.20%	16.30%	—	—	—	—	—	—	—
	18.31%	12.30%	21.40%	23.40%	20.80%	17.40%	14.40%	12.50%	17.10%	—
	-12.49%	-5.30%	31.10%	44.10%	22.40%	7.80%	41.70%	46.60%	-7.40%	—
	—	-67.70	-83.90	—	—	—	—	—	—	—
	—	0.75	0.71	—	—	—	—	—	—	—
	—	0.11	0.06	—	—	—	—	—	—	—
	—	290.39	168.95	—	—	—	—	—	—	—
	—	163.9	119.9	—	—	—	—	—	—	—
Balance sheet
	—	3,919	3,192	—	—	—	—	—	—	—
	—	1,942	1,917	—	—	—	—	—	—	—
	—	51.23	8.70	—	—	—	—	—	—	—
	—	531.17	349.73	—	—	—	—	—	—	—
	—	433.84	285.57	—	—	—	—	—	—	—
	—	103.45	65.58	—	—	—	—	—	—	—
	—	1,255	1,038	—	—	—	—	—	—	—
	—	122.67	86.42	—	—	—	—	—	—	—
	—	575.52	370.17	—	—	—	—	—	—	—
	—	341.62	177.65	—	—	—	—	—	—	—
	—	289.53	177.65	—	—	—	—	—	—	—
	—	52.09	0.00	—	—	—	—	—	—	—
	—	3,149	2,766	—	—	—	—	—	—	—
Cash flow
	—	240.69	241.09	—	—	—	—	—	—	—
	—	-225.38	-1,191	—	—	—	—	—	—	—
	—	20.15	952.93	—	—	—	—	—	—	—
	—	308.39	324.99	—	—	—	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	431.10	443.01	418.86	416.54	384.05	420.97	410.94	402.47	367.43	360.93	320.86	319.90
	28.65	15.12	29.55	33.72	41.10	23.95	21.75	27.25	16.83	15.66	16.57	12.79
	459.75	458.14	448.41	450.26	425.14	444.92	432.69	429.71	384.26	376.59	337.43	332.68
	341.11	351.33	335.60	332.26	308.08	328.42	319.30	312.78	288.18	282.62	255.34	254.72
	152.75	136.96	128.82	144.32	128.75	135.12	135.43	145.02	125.30	117.03	111.46	104.88
	1.77	1.36	1.58	1.23	0.86	2.51	3.32	1.21	0.89	1.35	1.05	2.85
	88.91	78.10	85.24	82.90	69.93	71.98	72.79	73.04	66.40	62.29	57.06	55.10
	4.38	3.89	3.94	2.78	2.81	2.17	3.13	3.13	2.98	2.93	3.35	2.10
	26.47	25.51	25.06	24.15	22.84	21.33	20.83	20.11	18.98	16.16	15.53	15.33
	98.55	95.97	86.86	96.33	90.44	89.03	78.32	84.81	74.62	72.28	63.68	64.04
	118.64	106.81	112.82	118.01	117.06	116.50	113.39	116.93	96.08	93.97	82.09	77.96
	0.00	0.00	-6.80	0.00	0.00	0.00	—	—	—	—	—	—
	118.64	106.81	106.02	118.01	117.06	116.50	113.39	116.93	96.08	93.97	82.09	77.96
	30.52	26.18	27.63	28.96	29.14	29.84	28.24	29.71	23.77	23.44	20.63	18.76
	88.12	80.62	78.38	89.05	87.93	86.66	85.15	87.22	72.30	70.53	61.46	59.21
	8.69	7.95	7.73	8.79	8.68	8.40	8.48	8.99	7.53	7.35	6.41	6.17
Key metrics
	149.49	136.21	135.02	144.94	142.71	140.00	137.35	140.17	118.04	113.06	100.97	95.39
	34.70%	30.70%	32.20%	34.80%	37.20%	33.30%	33.40%	34.80%	32.10%	31.30%	31.50%	29.80%
	20.40%	18.20%	18.70%	21.40%	22.90%	20.60%	20.70%	21.70%	19.70%	19.50%	19.20%	18.50%
	—	3.50%	—	4.10%	—	4.20%	—	—	—	—	—	—
	12.30%	5.20%	1.90%	3.50%	4.50%	16.60%	28.10%	25.80%	—	—	—	—
	0.20%	-7.00%	-8.00%	2.10%	21.60%	22.90%	38.50%	47.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	1,710	1,662	1,602	1,307	1,068	879.36	747.38	646.16	586.69	509.70
	107.04	119.92	89.77	58.18	36.29	38.73	19.29	18.58	15.84	14.37
	1,817	1,782	1,692	1,365	1,104	918.09	766.67	664.75	602.53	524.07
	1,360	1,328	1,249	1,031	867.50	723.37	593.29	542.96	502.04	427.71
	562.85	538.86	540.88	432.77	394.84	331.28	245.91	207.01	185.22	167.14
	5.94	5.04	7.93	7.02	5.21	10.66	3.08	0.71	14.54	4.37
	335.15	313.15	280.08	228.85	188.35	149.89	130.74	127.34	109.77	93.93
	14.99	13.43	11.41	10.74	8.30	3.61	7.91	17.66	11.29	9.50
	101.19	97.90	80.84	62.05	55.64	52.54	46.31	39.28	36.36	28.41
	377.71	372.71	344.58	257.15	212.92	170.75	148.42	147.19	138.81	123.00
	456.28	454.70	442.89	334.89	236.83	194.72	173.38	121.78	100.49	96.36
	-6.80	-6.80	0.00	—	—	—	—	—	—	—
	449.48	447.89	442.89	334.89	236.83	194.72	173.38	121.78	100.49	96.36
	113.29	111.91	111.56	83.17	57.78	48.70	43.87	29.40	34.21	26.16
	336.17	335.99	331.33	251.72	179.04	146.02	129.51	92.38	66.28	70.20
	33.16	33.15	33.40	26.24	18.67	15.23	14.54	10.47	7.51	—
Key metrics
	565.66	559.22	535.14	407.68	300.77	250.87	227.60	178.72	148.14	134.27
	33.09%	33.60%	33.40%	31.20%	28.20%	28.50%	30.50%	27.70%	25.30%	26.30%
	19.66%	20.20%	20.70%	19.30%	16.80%	16.60%	17.30%	14.30%	11.30%	13.80%
	—	14.70%	16.20%	—	—	—	—	—	—	—
	5.63%	3.80%	22.50%	22.40%	21.50%	17.70%	15.70%	10.10%	15.10%	—
	-3.11%	1.40%	31.60%	40.60%	22.60%	12.70%	40.20%	39.40%	-5.60%	—
	—	-50.31	-88.34	—	—	—	—	—	—	—
	—	0.73	0.71	—	—	—	—	—	—	—
	—	0.08	0.06	—	—	—	—	—	—	—
	—	242.49	169.31	—	—	—	—	—	—	—
	—	140.3	116.9	—	—	—	—	—	—	—
Balance sheet
	—	3,550	3,140	—	—	—	—	—	—	—
	—	1,640	1,860	—	—	—	—	—	—	—
	—	5.94	0.55	—	—	—	—	—	—	—
	—	442.25	340.09	—	—	—	—	—	—	—
	—	281.34	249.87	—	—	—	—	—	—	—
	—	92.78	62.85	—	—	—	—	—	—	—
	—	1,200	1,030	—	—	—	—	—	—	—
	—	84.71	76.77	—	—	—	—	—	—	—
	—	419.27	341.80	—	—	—	—	—	—	—
	—	248.43	169.86	—	—	—	—	—	—	—
	—	245.90	169.86	—	—	—	—	—	—	—
	—	2.53	0.00	—	—	—	—	—	—	—
	—	3,053	2,744	—	—	—	—	—	—	—
Cash flow
	—	245.20	236.65	—	—	—	—	—	—	—
	—	-267.84	-1,191	—	—	—	—	—	—	—
	—	28.03	952.93	—	—	—	—	—	—	—
	—	295.51	324.99	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +15.89%
Sales CAGR 5Y: +17.34%
Profit CAGR 3Y: +23.35%
Profit CAGR 5Y: +21.01%
Sales YoY (TTM): +5.63%
Profit YoY (TTM): -3.11%

Consolidated

Sales CAGR 3Y: +18.91%
Sales CAGR 5Y: +18.98%
Profit CAGR 3Y: +21.40%
Profit CAGR 5Y: +18.74%
Sales YoY (TTM): +18.31%
Profit YoY (TTM): -12.49%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 62.44%

Quarter	September 2026	June 2026
Promoter %	62.44%	62.44%

Holder	Type	Holding	Previous	Change
EZEKIEL GLOBAL BUSINESS SOLUTIONS LLP	Promoter Group	12.20%	12.20%	0.00%
RISHI BAID	Promoter	9.59%	9.59%	0.00%
ZETTA MATRIX CONSULTING LLP	Promoter Group	8.21%	8.21%	0.00%
HIMANSHU BAID	Promoter	7.80%	7.80%	0.00%
QUANT MUTUAL FUND - QUANT SMALL CAP FUND	Public	4.56%	—	—
HIMANSHU BAID (HUF)	Promoter Group	3.79%	3.79%	0.00%
VCB TRADING LLP	Promoter Group	3.49%	3.49%	0.00%
JAI POLYPAN PRIVATE LIMITED	Promoter Group	3.26%	—	—
SMT.MUKULIKA BAID	Promoter	3.02%	3.02%	0.00%
RISHI BAID (HUF)	Promoter Group	2.74%	2.74%	0.00%
LIGHTHOUSE INDIA FUND IV AIF	Public	2.33%	2.33%	0.00%
JUGAL KISHORE BAID	Promoter	2.25%	2.25%	0.00%
AXIS MAX LIFE INSURANCE LIMITED AC REVERSIONARY BONUS PARTICIPATING EQUITY	Public	2.08%	—	—
VISHAL BAID	Promoter	1.66%	1.66%	0.00%
UTI NIFTY 500 INDEX FUND	Public	1.47%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Poly Medicure Ltd	16,093	1,587.65	51.43	13.20%	+18.31% TTM	-12.49% TTM	-18.70%
MOLBIO DIAGNOSTICS LIMITED	15,901	1,379.80	—	—	—	—	—
Sahajanand Medical Technologies Limited	4,939	485.85	—	—	—	—	—
FISCHER MEDICAL VENTURES LIMITED	1,655	25.29	59.29	12.70%	+195.94% TTM	+371.52% TTM	-73.00%
Tarsons Products Limited	1,651	310.35	148.83	4.80%	+10.63% TTM	-59.68% TTM	+7.85%
Laxmi Dental Limited	1,036	188.30	31.98	11.50%	+13.07% TTM	+24.85% TTM	-40.71%
Hemant Surgical Industries Limited	884	608.10	—	19.50%	—	—	+109.69%
Fabtech Technologies Limited	591	133.05	16.61	11.60%	—	—	-44.16%
Prevest Denpro Limited	480	400.00	—	21.90%	—	—	-23.80%
Nureca Limited	288	301.65	60.46	3.40%	+33.66% TTM	+15.82% TTM	+17.10%
EARKART LIMITED S	161	117.00	32.59	12.10%	—	—	-48.46%
CHOKSI ASIA LIMITED S	120	210.00	23.08	18.40%	+21.40% TTM	+132.74% TTM	+97.28%
Shree Pacetronix Ltd	63	169.15	19.60	25.00%	+22.63% TTM	+208.57% TTM	-38.65%
Amkay Products Limited S	46	53.50	20.04	13.40%	—	—	+13.88%
KMS Medisurgi Limited S	44	132.80	177.07	4.80%	—	—	—
Royal Sense Limited	36	67.70	—	26.10%	—	—	-70.69%
GKB Ophthalmics Ltd.	31	62.00	5.67	9.60%	+29.95% TTM	+170.50% TTM	-9.48%
Centenial Surgical Suture Ltd. S	26	71.96	-17.99	2.60%	+6.70% TTM	+26.29% TTM	-33.37%
Transpact Enterprises Limited S	4	100.70	—	14.50%	—	—	-57.35%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Intimation of earnings call on Financial Results for the Quarter and Half -Year ended on September 30, 202631 Oct 2026 · Company Update / Analyst / Investor Meet
Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve a. The Unaudited Financial Results ....29 Oct 2026 · Board Meeting / Board Meeting
Please find enclosed Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 201813 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Company Informed the Exchange about the Closure of Trading Window.28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Enclosed24 Sep 2026 · Company Update / General
Enclosed23 Sep 2026 · Company Update / General
Enclosed21 Sep 2026 · Company Update / General
Enclosed18 Sep 2026 · Company Update / General
Scrutinizer Report and Voting Results7 Sep 2026 · AGM/EGM / AGM
Outcome of the 31st Annual General Meeting of the Poly Medicure Limited.5 Sep 2026 · AGM/EGM / AGM
Enclosed2 Sep 2026 · Company Update / General
Enclosed25 Aug 2026 · Company Update / General
Enclosed22 Aug 2026 · Company Update / General
Enclosed20 Aug 2026 · Company Update / General
Enclosed17 Aug 2026 · Company Update / General
Copy of the news paper publication15 Aug 2026 · Company Update / Newspaper Publication
Enclosed14 Aug 2026 · Company Update / General
Enclosed14 Aug 2026 · Company Update / General
Enclosed14 Aug 2026 · Corp. Action / Record Date
Record Date/ Book Closure Date14 Aug 2026 · Corp Action / Dividend Updates
Enclosed14 Aug 2026 · Corp. Action / Book Closure
Enclosed14 Aug 2026 · AGM/EGM / AGM
Enclosed14 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Enclosed14 Aug 2026 · AGM/EGM / AGM
Enclosed10 Aug 2026 · Company Update / Analyst / Investor Meet
enclosed10 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
The company submitted the Monitoring Agency Report for the Quarter ended 30th June, 2026.10 Aug 2026 · Company Update / Monitoring Agency Report
ENCLOSED10 Aug 2026 · Company Update / Newspaper Publication
ENCLOSED7 Aug 2026 · Company Update / Investor Presentation
The Company informed about the Resignation of Mr. Ravi Prakash the Deputy Company Secretary of the Company w.e.f. close of business hours on 10th August, 2026.7 Aug 2026 · Company Update / Change in Management
ENCLOSED7 Aug 2026 · Company Update / General
The Company allotted the 1975 Equity Shares under ESOP Scheme, 2020.7 Aug 2026 · Company Update / Allotment of ESOP / ESPS
ENCLOSED7 Aug 2026 · Result / Financial Results
ENCLOSED7 Aug 2026 · Board Meeting / Outcome of Board Meeting
ENCLOSED7 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation for the Investers/Analyst Call for the Financial Results of First quarter ended on 30th June, 2026.5 Aug 2026 · Company Update / Analyst / Investor Meet
Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve enclosed31 Jul 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 201814 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Enclosed8 Jul 2026 · Company Update / General
The Company informed the Exchange about the Trading Window Closure29 Jun 2026 · Insider Trading / SAST / Closure of Trading Window

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 3.5000	28 Aug 2026	29 Aug 2026	—
Final Dividend - Rs. - 3.5000	18 Sep 2025	18 Sep 2025	—
Final Dividend - Rs. - 3.0000	19 Sep 2024	—	—

Board meetings

5 Nov 2026 Board Meeting - Financial Results
7 Aug 2026 Board Meeting - Financial Results